Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1438Pancreatic Neoplasms 862Carcinoma, Hepatocellular 745Stomach Neoplasms 650Colonic Neoplasms 448Rectal Neoplasms 406Esophageal Neoplasms 400Breast Neoplasms 332Carcinoma, Non-Small-Cell Lung 328Neoplasms 307Liver Neoplasms 283Cholangiocarcinoma 244Ovarian Neoplasms 243Lung Neoplasms 239Neoplasm Metastasis 237Gastrointestinal Neoplasms 219Melanoma 186Esophageal Squamous Cell Carcinoma 167Prostatic Neoplasms 166Biliary Tract Neoplasms 161Endometrial Neoplasms 143Uterine Cervical Neoplasms 130Squamous Cell Carcinoma of Head and Neck 129Head and Neck Neoplasms 114Carcinoma, Renal Cell 114Sarcoma 101Urinary Bladder Neoplasms 97Adenocarcinoma Of Esophagus 90Triple Negative Breast Neoplasms 87Anus Neoplasms 83

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Gastrointestinal Tumors × Gastrointestinal × 1 year × Clear all
NCT04612712 2026-05-01

A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 1/2 Terminated
15 enrolled
Gastrointestinal

Advanced Gastrointestinal Tumors

NCT06197178 2026-02-06

A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

Peking University

Phase 1 Terminated
17 enrolled
Gastrointestinal

Advanced Gastrointestinal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡